QuidelOrtho Stock Sinks To 52-Week Low

The diagnostic healthcare products maker reported preliminary Q1 revenue of $615 million to $620 million, well below the $680.59 million consensus. The miss of roughly 9% to 10% points to softer-than-expected operating performance and may pressure the stock. This is a notable company-specific earnings update rather than a broader sector event.

Analysis

The diagnostic healthcare products maker reported preliminary Q1 revenue of $615 million to $620 million, well below the $680.59 million consensus. The miss of roughly 9% to 10% points to softer-than-expected operating performance and may pressure the stock. This is a notable company-specific earnings update rather than a broader sector event.